Updates from CTOS 2026
Dr. Pawel Sobczuk will share key GIST-related research findings and clinical insights from the CTOS 2026 Annual Meeting, highlighting the latest developments in GIST research and treatment.
2 events found.
Events
-
-
-
Exploring a New Clinical Trial for KIT-Mutant GIST
Dr. Candace Haddox will discuss a new clinical trial combining ripretinib and navlimetostat for patients with KIT-mutant GIST and MTAP gene deletion, including eligibility and enrollment details.